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Envenomation by Loxosceles spider bite leads to a set of signs and symptoms, called lox-
oscelism,which inmost casesmanifests through the dermonecrotic frame. The development
of a smaller size animalmodel, of easy handling andmaintenance, and lower cost is needed to
study the loxoscelism pathogenesis. The inﬂammatory effects of the Loxosceles similis crude
venom was evaluated considering neutrophil and macrophage activation, vasodilatation,
hyperhaemia, edema and hemorrhage and TNF-a and VEGF production using the murine
sponge implant model. Thirty two male Swiss mice (6–8 weeks old) were implanted subcu-
taneously with polyether–polyurethane sponge discs. Fourteen days post implantation,
animals were separated into two groups: (1) control group – 16mice received 30 mL of saline
intra-implant; (2) treated group-sixteen mice injected with 0.5 mg/30 mL of L. similis crude
venom intra-implant. The animals were euthanized with xylazine/ketamine after 1 and 4 h
post- injection. Microscopically, implants of the treated groups presented an acute inﬂam-
mation characterized by: neutrophilic inﬁltrate, edema, vasodilatation hyperhaemia, and
severe hemorrhage. Some vessels presented ruptured walls. Under morphometric analysis,
vessel areawas bigger in the treated groups comparedwith the control ones. The biochemical
parameters, hemoglobin content, inﬂammatory enzyme activities (myeloperoxidase and n-
acethyl-b-D glucosaminidase) and levels of the cytokines, TNF-a and VEGF, were also signiﬁ-
cantly higher in the venom-treated groups. The effects of Loxosceles venom in the granulation
tissue of the implant inmicewere similar to those observed in cutaneous loxoscelism in other
species (humanandrabbits). Consequently, themurine sponge implantmodel provides a new
method to investigate cellular/molecularmechanismsassociatedwithcutaneous loxoscelism.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Loxoscelism is a set of signs and symptoms caused by the
bite of spiders of the genus Loxosceles (Da Silva et al., 2004).
Loxosceles (Araneae, Sicariidae) can be found in temperate
and tropical regions of America, Oceania, Asia, Africa andgia Geral, Brazil.
. Pereira).
lsevier OA license.Europe (SwansonandVetter, 2006;Hoganet al., 2004; Souza
et al., 2008). This genus represents apublic healthproblemin
Brazil, mainly in South and Southeast regions, with more
than 3000 cases reported annually by theMinistry of Health
(Hogan et al., 2004). Usually, the clinical manifestations of
loxoscelism are characterized by necroulcerative dermatitis
at the site of the bite (83.3% of the cases). However the
envenoming can also cause systemic effects (16% of the
victims) leading to acute renal failure, which may be lethal
N.B. Pereira et al. / Toxicon 59 (2012) 672–679 673(Málaque et al., 2002; Hogan et al., 2004; Abdulkader et al.,
2008). Locally, lesions caused by Loxosceles venom present
edema, hemorrhage, inﬂammation with predominance of
neutrophils, rhabdomyolisis, damage to the vessels wall,
thrombosis, and dermonecrosis (Futrell,1992; Ospedal et al.,
2002; Pereira et al., 2010). In addition, according to some
studies, Loxosceles venom causes cytoplasmic vacuolization,
loss of adhesion (Hogan et al., 2004; Veiga et al., 2000; Veiga
et al., 2001) and apoptosis of endothelial cells (Pereira et al.,
2010). The family of Loxtox proteins (Kalapothakis et al.,
2007), such as: sphingomyelinase-D, SMA protein, phos-
pholipase-D dermonecrotic protein (DP) and dermonecrotic
factors (DNF) were found and characterized in the venom of
Loxosceles and were associated with local and systemic lox-
oscelism (Barbaro et al., 2005; Felicori et al., 2006;DaSilveira
et al., 2007). The systemic and local effects of the venom are
well described in human, rabbit, and guinea pig cutaneous
tissue. The use of the murine model in loxoscelism study is
restrained to inﬂammatory events analysis, since the der-
monecrotic lesion does not develop in mouse following
intradermal injection of the venom (Sunderkötter et al.,
2001; Barbaro et al., 2010). Further understanding of intra-
cellular andmolecular mechanisms of loxoscelism is limited
because rabbit model is far more expensive. Additionally,
only few scientiﬁc probes are available for investigation of
intracellular andmolecular events of the envenoming in this
specie. Thus, an animal model that would allow the investi-
gation of these events is highly advantageous. The subcuta-
neous implantation of sponges have been used in several
studies, because it is a model that resembles a cell culture
in vivo by inducing an ampliﬁed inﬂammatory foreign body
reaction that progresses to the formation of a highly vascular
granulation tissue in which various components of subcu-
taneous tissue can be analyzed by biochemical, functional
and histological parameters (Campos et al., 2008; Parrilha
et al., 2011). Previously, we have investigated the effects of
Bothrops venom on blood ﬂow of the ﬁbrovascular tissue
induced by synthetic matrix implanted subcutaneously in
mice (Vieira et al., 1992). We reasoned that this model could
beused to study theactionsof Loxoscelesvenominmice thus,
providing a new tool to investigate not only the inﬂamma-
tory effects of the venom, but also the mechanisms of the
injury. In this study, we set up a methodology based on
subcutaneous implantation of spongematrix to evaluate the
inﬂammation pattern (neutrophil and macrophage inﬁltra-
tion, vasodilatation, hyperhaemia, edema and hemorrhage)
induced by Loxosceles venom in mice.
2. Materials and methods
2.1. Venom extraction
The venom was extracted from the venom glands of
adult animals by maceration and centrifugation according
to Silvestre et al. (2005), and frozen at 80 C until use.
2.2. Animals
Thirty two 6–8 weeks old male Swiss mice were housed
individually and provided with chow pellets and water ad
libitum. The light/dark cycle was 12:12 h with lights on at7:00 a.m. and lights off at 7:00 p.m. Housing, anesthesia,
and postoperative care concurred with the guidelines
established by our local Institutional Animal Welfare
Committee. The present study was approved by the Ethics
Committee in Animal Experimentation (CETEA) of Uni-
versidade Federal de Minas Gerais (UFMG) process number
229/09 approved in June 9, 2010.
2.3. Preparation of sponge discs and implantation
Discs of Polyether–polyurethane sponge (Vitafoam Ltd.,
Manchester, UK), 6 mm thick, and 11 mmdiameter (Fig. 1A)
were soaked overnight in 70% v/v ethanol and boiled in
distilled water for 15 min before implantation. Animals
were anesthetizedwith xilasin/ketamin (1 mg/kg, Syntec of
Brazil), the dorsal fur was shaved and the skin antissepsy
was made with 70% ethanol. The sponge discs were asep-
tically implanted into a subcutaneous pouch, through
a 1 cm long dorsal mid-line incision. Post-operatively,
animals were monitored for any sign of infection at the
operative site, discomfort or distress.
2.4. Venom injection and implant removal
Fourteen days post implantation, animals were sepa-
rated into two groups: (1) control group – sixteenmice that
injected with 30 mL of saline intra-implant; (2) treated
group – sixteen mice injected with 0.5 mg/30 mL of Lox-
osceles similis crude venom intra-implant. Sixteen animals
(8 control and 8 treated) were euthanized at 1 h and the
remaining sixteen mice (8 control and 8 treated) 4 h post-
injection. Five implants of each group were removed,
weighed and frozen for biochemical analysis. Three sets of
implants from each group were kept for histological
analysis.
2.5. Histological staining and morphometric analysis
For each time interval 3 implants from both groups
(control and treated) were ﬁxed in 10% buffered formalin,
pH 7.4 and processed for the parafﬁn embedding. Sections
5 mm thick were stained by hematoxylin/eosin (HE) for
histological and morphometrical analysis. The vasodilata-
tion induced by the venom was measured morphometri-
cally. For that, images of 25 ﬁelds per slide by means of
a planapochromatic objective (20) in light microscopy
(Olympus BX-640) were obtained. The images were digi-
talized through a JVC TK-1270/JGB microcamera and
analyzed using the software Kontron Electronic, Carl Zeiss –
KS300, version 2.
2.6. Hemoglobin (Hb) extraction and dosage
Blood content intra-implantwas assessed by the amount
of Hb detected in the tissue using the Drabkin method
(Drabkin and Austin, 1932; Campos et al., 2008). Each
implant was homogenized (Tekmar TR-10, Cincinnati, OH)
in 5 mL of Drabkin reagent (Labtest, São Paulo, Brazil) and
centrifuged at 12,000 rpm for 20 min. The supernatants
were ﬁltered through a cellulose ester membrane (0.22 mm,
Millipore, São Paulo, Brazil). The Hb concentration in the
Fig. 1. Effects of intra-implant injection of the L. similis crude venom on vascular parameters. (A) Control group – implant 4 hour post injection of 30 ml of saline
and (B) treated group – implant 4 hour post injection of 30 ml of L. similis crude venom (0.5 mg) – note area of hemorrhage (blue arrow); (C) the amount of
hemoglobin (Hb) is higher in the venom treated group 4 h after inoculation The results are expressed as mean standard error of the mean of ﬁve animals for
each group (P< 0.05); Kruskal–Wallis test and Dunn’s post test. (C1 and C4¼ control groups 1 h and 4 h post injection of saline, respectively) (T1 and T4¼ treated
groups 1 h and 4 h post injection of venom, respectively) (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.).
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measuring absorbance at 540 nm using an enzyme linked
immunosorbent assay (ELISA) plate reader and compared
against a standard curve of Hb. The content of Hb in the
implant was expressed as mgHb/mg of wet tissue.
2.7. Tissue extraction and determination of MPO
(myeloperoxidase) and NAG (N-acetylglucosaminidase)
activities
The extent of neutrophil accumulation in the implants
was measured by assaying MPO activity as previously
described (Campos et al., 2008). The implants were
weighed, homogenized in 2 mL of phosphate buffer (0.1 M
NaCl, 0.02 M Na3PO4, 0.015 M NaEDTA, pH 4.7), centrifuged
at 12,000 rpm for 10 min. The pellets were then resus-
pended in 2 mL of phosphate buffer (0.05 M Na3PO4, pH
5.4) containing 0.5% hexadecyltrimethylammonium
bromide (HTAB) followed by three freeze-thaw cycles usingliquid nitrogen. MPO activity in the supernatant samples
was assayed by measuring the change in absorbance
(optical density, OD) at 450 nm using tetramethylbenzidine
(1.6 mM) and H2O2 (0.3 mM). The reaction was terminated
by the addition of 50 mL of H2SO4 (4M). Results were
expressed as change in OD/g of wet tissue. The inﬁltration
of mononuclear cells into the implants was quantitated by
measuring the levels of the lysosomal enzyme NAG present
in high levels in activated macrophages. The implants were
homogenized in 2 mL NaCl solution (0.9% w/v) containing
0.1% v/v Triton X-100 (Promega, Madison, WI) and centri-
fuged (3000 rpm; 10 min at 4 C). The resulting superna-
tant (100 mL) was incubated for 10 min with 100 mL of p-
nitrophenyl-N-acetyl-b-D-glucosaminide (Sigma, Saint
Louis, MO) prepared in citrate/phosphate buffer (0.1 M
citric acid, 0.1 M Na2HPO4; pH 4.5) to yield a ﬁnal
concentration of 2.24 mM. The reactionwas stopped by the
addition of (100 mL) of 0.2 M glycine buffer (pH 10.6).
Hydrolysis of the substrate was determined by measuring
N.B. Pereira et al. / Toxicon 59 (2012) 672–679 675the absorption at 400 nm. Results were expressed as
change in OD/g of wet tissue.
2.8. Measurement of VEGF (Vascular Endothelial Growth
Factor) and TNF-a (tumor necrosis factor-a)
The measurement of VEGF and TNF-a in the implants
was carried out spinning (10,000 rpm for 30 min) 100 mL of
the supernatant prepared for hemoglobin dosage (item
2.6). The analysis was made with Immunoassay Kits (R & D
Systems, USA) following the manufacturer’s protocol.
Brieﬂy, dilutions of cell-free supernatants were added in
duplicate to ELISA plates coated with a speciﬁc murine
monoclonal antibody against VEGF and TNF-a, followed by
the addition of a secondary horseradish-peroxidase-
conjugated polyclonal antibody (goat anti-mouse VEGF
and goat anti-mouse TNFa). After washing to remove any
unbound antibody-enzyme reagent, a substrate solution
(50 mL of a 1:1 solution of hydrogen peroxide and tetra-
methylbenzidine (10 mg/mL) in DMSO) was added to the
wells. The color development was stopped, after 20 min of
incubation, with 2N sulphuric acid (50 mL) and the inten-
sity of the color was measured at 540 nm on a spectro-
photometer (E max, Molecular Devices). Standards were
0.5 log10 dilutions of recombinant murine chemokines
from 7.5 to 1000 pgmL (100 mL). The results were
expressed as picogram of cytokine/mg of wet tissue.
2.9. Statistical analysis
Results are presented as mean standard deviation.
Comparisons between two groups were carried out using
Student’s t-test for unpaired data. Comparisons between
three or more groups were carried out using one-way anal-
ysis of variance (ANOVA) and differences between groups
were assessed using Newman–Keuls (parametric data).
When the groups distribution showed no normal distribu-
tion (nonparametric) Kruscal Wallis test and Dunn post test
were applied. A P< 0.05 was considered signiﬁcant.
3. Results
3.1. Macroscopy and hemoglobin content of the implants
At the 14th day post implantation, the sponge discs
became enveloped by a ﬁbrous connective tissue (Fig. 1A)
containing visible blood vessels. Intra-implant venom
injection resulted in intense hemorrhage more pronounced
at 4 h after injection (Fig.1B). Hemorrhage and hyperhaemia
were conﬁrmed by the amount of hemoglobin extracted
fromthevenom-treated implants (Fig.1C). The treatedgroup
presented mean hemoglobin values of 4.11.2 mg/mg wet
tissue at one hour post-injection and 4.7 0.9 mg/mg wet
tissue at 4 h post-injection. These values were higher than
those of the control groups (1.4 0.14 mg/mg wet tissue at 1
hour; and 1.3 0.3 mg/mg wet tissue at 4 h).
3.2. Microscopical analysis
Under light microscopy, the implant of the control
group contained an organized granulation tissue composedby ﬁbroblasts and blood vessels and an inﬂammatory
inﬁltrate of neutrophils and macrophages (Fig. 2A). In the
venom-treated group implant, an intense neutrophilic
inﬂammatory inﬁltrate, vasodilatation, hyperhaemia and
edema were present at both time points (Fig. 2B) charac-
terizing an acute inﬂammation. In addition, an intense
hemorrhage and the rupture of some vessel walls, was
noted in implants four hour after injection (Fig. 3A–F).
Moreover, the average vessel areawas higher in the venom-
treated groups at both time points studied (Fig. 2C). The
average vascular area of the control groups was
1.1901.420 mm2 (1 hour post saline injection) and
1.5951.769 mm2 (4 h post saline injection). In the treated-
groups the mean vascular area was 2.0271.769 mm2 and
5.480 7.134 mm2, at 1 and 4 hour post venom injection,
respectively (p< 0.0001).
3.3. Action of Loxosceles venom in implants levels of MPO
(myeloperoxidase) and NAG (N-acetyl-b-D-glucosaminidase)
The levels of MPO activity (a marker for activated
neutrophils) in the treated group (4 h post injection) were
higher compared with that of control groups (Fig. 4A). The
MPO values of the treated groups were 0.27 0.05 and
0.32 0.14 while control groups were 0.13 0.02 and
0.16 0.07 for the intervals of 1 and 4 h, respectively. The
levels of NAG activity (the marker for monocytes/macro-
phages) were also signiﬁcantly higher in the treated group
(4 h after injection) than that in control group (Fig. 4B). The
NAG values of the treated group were 47715521 and
5325 676 while control groups were 33374479 and
3154 3791 or the intervals of 1 and 4 hours, respectively.
3.4. Measurement of VEGF (Vascular Endothelial Growth
Factor) and TNF- (tumor necrosis factor-a)
The venom treated group showed higher levels of intra-
implant VEGF (Fig. 5A) than the control one. The average
values of the treated groupwere 1.51.1 and 0.97 0.7 pg/
mg of tissue 1 and 4 hours after inoculation, respectively
versus 0.09 0.13 and 0.12 0.05 pg/mg of tissue (1 and 4
hours after injection, respectively) of the control group. The
inﬂammatory cytokine TNF-a (Fig. 5B) was also higher in
the treated group compared with the saline treated
implants. The average values of the treated group were
3961245 and 408 8778 pg/mg of tissue 1 and 4 hours
after inoculation, respectively versus 1474 2236 and
2026 3015 pg/mg of tissue (1 and 4 hours after injection,
respectively) of the control group.
4. Discussion
Loxoscelic accidents can induce clinical manifestations:
locally (dermonecrotic skin lesions) and/or systemically.
The development of one or another will depend on several
factors related to individuals, such as nutritional status, age,
site of the bite, amount of injected venom, susceptibility to
the venom and the time passed between the accident and
treatment (Gajardo-Tobar, 1966; Schenone et al., 1989;
Barbaro et al., 1994; Da Silva et al., 2004). Loxosceles bites
can cause dermonecrosis in humans, guinea pigs, and
Fig. 2. Histological sections of subcutaneous implants. (A) Implant of control group at 4 h post injection – granulation tissue at day 14, observe the presence of
newly formed blood vessels (black arrows) containing red blood cells; (B) implant of the venom-treated group at 4 h post injection – vasodilation and hyperaemia
are observed (black arrows) (stain¼HE); (C) blood vessels area (mm2) of control group and treated group. The results are expressed as mean standard deviation
of the mean, ***P< 0.0001; Kruskal–Wallis test and Dunn’s post test. (C1 and C4¼ control groups 1 h and 4 h post injection of saline, respectively), (T1 and
T4¼ treated groups 1 h and 4 h post injection of venom, respectively).
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thereby showing differential mammalian toxicity due to
unknown reason. The rabbit is the animal model used for
the study of loxoscelism, however, the maintenance of
these animals is very expensive and their handling is
cumbersome for routine laboratory work. Thus, we decided
to work with an animal model of smaller size (mice), easy
handling and maintenance, lower cost, besides allowing
a better control of the experiment. The present study aimed
to evaluate the viability of the sponge implant model in
mice, considering the need of further investigation of the
body’s reaction to the venom. In this model, a ﬁbrovascular
tissue induced by subcutaneous implantation of a synthetic
matrix mimics the events of cutaneous wound healing
(inﬂammatory inﬁltrate cells, angiogenesis, ﬁbrogenesis) as
assessed by biochemical, histological, cellular and func-
tional parameters (Marques et al., 2011; Campos et al.,
2011; Andrade and Ferreira, 2009). Indeed, using this
model we have previously shown that intra-implant
injection of Bothrops jararaca venom resulted in
decreased blood ﬂow detected by slow 133Xenom washout
(Vieira et al., 1992). In the present study, it was possible to
observe biochemical and histological changes induced by
intra-implant injection of 0.5 mg of L. similis crude venom.
The alterations included an inﬂammatory inﬁltrate
predominantly neutrophilic at the injection site,vasodilatation, hyperhaemia, and edema, characterizing an
acute inﬂammation. Besides, hemorrhage, and rupture of
the vascular wall were also observed. Interestingly, these
events are similar to those observed by several authors in
rabbit, guinea pig and human but not in mice skin (Smith
and Micks, 1970; Patel et al., 1994; Ospedal et al., 2002;
Pereira et al., 2010; Sunderkötter et al., 2001; Ospedal
et al., 2002; Barbaro et al., 2010). The difference in sensi-
tivity between different species to spider venoms has been
attributed to many factors (tissue damage, secondary
vascular injury, release of inﬂammatory mediators) and to
insufﬁcient membrane lipid components such as sphingo-
myelin and products (He et al., 2001; Domingos et al.,
2003). It has been demonstrated that co-administration
of Loxosceles gaucho venom with sphingomyelin intrader-
mally in mice caused the development of an inﬂammatory
reaction at the site of injection. This effect has been
attributed to the ability of this molecule to trap the venom
for a long period preventing its diffusion systemically
(Domingos et al., 2003). It is possible that the pool of
molecules in the implant microenvironment was also able
to keep the Loxosceles similis venom allowing for its pro-
longed action in the newly formed ﬁbrovascular tissue. It
may be argued that the highly permeable nature of the
neovasculature would allow rapid diffusion of the venom.
However, the lytic activity of the venom promoting blood
Fig. 3. Histological sections of implants: (A) Implant of control group at 4 h post injection – note the well delineated blood vessels (black arrows) (stain¼HE); (B)
implant of the venom-treated group at 1 h post injection of L. similis venom – observe the dissociation of ﬁbers and cells (black arrows) (characterizing edema)
and area of hemorrhage (blue arrow) (stain¼HE); C–F – implant of the venom-treated group at 4 h post injection of L. similis venom; (C) note the rupture of the
vessel wall (black arrow) (Stain¼ PAS); (D–F) – neutrophilic inﬂammatory inﬁltrate: (D) diffuse and (E) focal; (F) detail of the neutrophilic inﬁltrate (stain¼HE)
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.).
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the site of injection. Further investigation will be necessary
to identify the nature of the molecules present in implant
compartment responsible for keeping the venom and/or its
active fraction.
The levels of cytokines VEGF (Vascular Endothelial
Growth Factor) and TNF-a (Tumor necrosis factor-a) werealso evaluated in the present study. There was a signiﬁcant
increase of these cytokines in the treated group 4 hours
after injection compared with the control group. The VEGF
is a multifunctional cytokine that exerts a variety of effects
on endothelial cells that together promote the formation of
new blood vessels, the protection of vascular cells, more-
over can lead to increased vascular permeability and
Fig. 4. Markers of inﬂammation in sponge implants. Neutrophils and macrophages recruited to the implant were determined through the activity of MPO (A) and
NAG (B), respectively. Overall, the inﬂammatory enzyme activities were increased after venom inoculation. Results are expressed as mean standard error of
mean. * P< 0.05; ** P< 0.01; Newman–Keuls post test.
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level of VEGF detected in the venom-treated implant
supports the increase of permeability that induced the
edema observed in the histological analysis. This result and
is in agreement with Desai et al. (2000) that showed that L.
deserta stimulated the expression of VEGF in cultured
human keratinocytes. Various studies have shown that
Loxosceles venom stimulates the production of various
cytokines. The TNF-a (tumor necrosis factor-a) is a potent
regulator of neutrophil chemotaxis, adhesion, priming,
phagocytosis, inﬂammatory mediator release and super-
oxide generation (Ballou et al., 1996). Furthermore,
Málaque et al. (1999) observed that L. gaucho venom causesFig. 5. Cytokines levels in sponge implants: the levels of both cytokines VEGF (A and
The results are expressed as mean standard error of mean. VEGF p values ** P<
Unpaired t test.alterations in primary cultures of keratinocytes and stim-
ulates TNF-a production. Recently, Souza et al. (2008)
reported high levels of IL-6 and TNF-a in a patient bitten
by Loxosceles spp. spider. Several cytokines have been
involved in severe envenomation, TNF-a, IL-1b and IL-6
(Petricevich, 2004). In our study, the high level of this
cytokine intra-implant induced by the venom may have
contributed for the local neutrophil chemotaxis and the
consequent neutrophilic inﬁltration observed in the histo-
logical analysis. The sensitivity of the method and its
applicability to detect the effects of Loxosceles venomwere
strongly supported by histological and biochemical
parameters. Thus, besides being less expensive and easeB) and TNF-a increased at both time intervals studied after venom injection.
0.006 (1) and 0.009 (4 h); TNF-a p values * P< 0.04 (1 h) and 0.02 (4 h);
N.B. Pereira et al. / Toxicon 59 (2012) 672–679 679handling the implantation technique induces a ﬁbrovas-
cular healing tissue that allows the characterization of
molecular and cellular events associated with loxocelism in
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